Medroxiprogesteronum en es it fr

Medroxiprogesteronum Brand names, Medroxiprogesteronum Analogs

Medroxiprogesteronum Brand Names Mixture

  • Lunelle (Medroxyprogesterone + Estradiol)

Medroxiprogesteronum Chemical_Formula

C22H32O3

Medroxiprogesteronum RX_link

http://www.rxlist.com/cgi/generic/medrox.htm

Medroxiprogesteronum fda sheet

Medroxiprogesteronum FDA

Medroxiprogesteronum msds (material safety sheet)

Medroxiprogesteronum Synthesis Reference

P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)

Medroxiprogesteronum Molecular Weight

344.488 g/mol

Medroxiprogesteronum Melting Point

220 - 223.5 oC

Medroxiprogesteronum H2O Solubility

22.2mg/L

Medroxiprogesteronum State

Solid

Medroxiprogesteronum LogP

3.606

Medroxiprogesteronum Dosage Forms

Tablets; Depo injection

Medroxiprogesteronum Indication

Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.

Medroxiprogesteronum Pharmacology

Medroxyprogesterone is a synthetic progestin more potent than progesterone.

Medroxiprogesteronum Absorption

Rapidly absorbed from GI tract

Medroxiprogesteronum side effects and Toxicity

Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.

Medroxiprogesteronum Patient Information

Medroxiprogesteronum Organisms Affected

Humans and other mammals